Repro Med Systems Stock Five Year Return
| KRMD Stock | USD 3.98 0.06 1.49% |
Repro Med Systems fundamentals help investors to digest information that contributes to Repro Med's financial success or failures. It also enables traders to predict the movement of Repro Stock. The fundamental analysis module provides a way to measure Repro Med's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Repro Med stock.
Repro | Five Year Return |
Repro Med Systems Company Five Year Return Analysis
Repro Med's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Repro Five Year Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Repro Med is extremely important. It helps to project a fair market value of Repro Stock properly, considering its historical fundamentals such as Five Year Return. Since Repro Med's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Repro Med's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Repro Med's interrelated accounts and indicators.
Click cells to compare fundamentals
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
Repro Return On Tangible Assets
Return On Tangible Assets |
|
According to the company disclosure, Repro Med Systems has a Five Year Return of 0.0%. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Repro Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Repro Med's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Repro Med could also be used in its relative valuation, which is a method of valuing Repro Med by comparing valuation metrics of similar companies.Repro Med is currently under evaluation in five year return category among its peers.
Repro Med ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Repro Med's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Repro Med's managers, analysts, and investors.Environmental | Governance | Social |
Repro Fundamentals
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.14 | ||||
| Profit Margin | (0.38) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 180.39 M | ||||
| Shares Outstanding | 45.84 M | ||||
| Shares Owned By Insiders | 6.29 % | ||||
| Shares Owned By Institutions | 54.38 % | ||||
| Number Of Shares Shorted | 479.11 K | ||||
| Price To Earning | 11.56 X | ||||
| Price To Book | 10.43 X | ||||
| Price To Sales | 6.00 X | ||||
| Revenue | 28.52 M | ||||
| Gross Profit | 15.37 M | ||||
| EBITDA | (9.4 M) | ||||
| Net Income | (13.74 M) | ||||
| Cash And Equivalents | 18.27 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 4.45 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 5.40 X | ||||
| Book Value Per Share | 0.45 X | ||||
| Cash Flow From Operations | (4.89 M) | ||||
| Short Ratio | 11.67 X | ||||
| Earnings Per Share | (0.26) X | ||||
| Target Price | 4.1 | ||||
| Number Of Employees | 82 | ||||
| Beta | 0.41 | ||||
| Market Capitalization | 184.95 M | ||||
| Total Asset | 28.46 M | ||||
| Retained Earnings | (23.31 M) | ||||
| Working Capital | 15.8 M | ||||
| Current Asset | 2.54 M | ||||
| Current Liabilities | 516.46 K | ||||
| Net Asset | 28.46 M |
About Repro Med Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Repro Med Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Repro Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Repro Med Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Repro Med Systems is a strong investment it is important to analyze Repro Med's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Repro Med's future performance. For an informed investment choice regarding Repro Stock, refer to the following important reports:Check out Repro Med Piotroski F Score and Repro Med Altman Z Score analysis. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repro Med. If investors know Repro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repro Med listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Earnings Share (0.26) | Revenue Per Share 0.674 | Quarterly Revenue Growth 0.215 | Return On Assets (0.14) |
The market value of Repro Med Systems is measured differently than its book value, which is the value of Repro that is recorded on the company's balance sheet. Investors also form their own opinion of Repro Med's value that differs from its market value or its book value, called intrinsic value, which is Repro Med's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repro Med's market value can be influenced by many factors that don't directly affect Repro Med's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repro Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repro Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.